Functional immune cell–astrocyte interactions
暂无分享,去创建一个
[1] A. Abate,et al. Barcoded viral tracing of single-cell interactions in central nervous system inflammation , 2021, Science.
[2] Kira E. Poskanzer,et al. Reactive astrocyte nomenclature, definitions, and future directions , 2021, Nature Neuroscience.
[3] J. Gommerman,et al. The Ins and Outs of Central Nervous System Inflammation-Lessons Learned from Multiple Sclerosis. , 2021, Annual review of immunology.
[4] S. Hauser,et al. Antigen Presentation by B Cells in Multiple Sclerosis. , 2021, The New England journal of medicine.
[5] Jasmin Herz,et al. Functional characterization of the dural sinuses as a neuroimmune interface , 2021, Cell.
[6] B. Becher,et al. Gut-licensed IFNγ+ NK cells drive LAMP1+TRAIL+ anti-inflammatory astrocytes , 2021, Nature.
[7] B. Khakh,et al. Behaviorally consequential astrocytic regulation of neural circuits , 2020, Neuron.
[8] W. Yung,et al. Astrocyte-secreted IL-33 mediates homeostatic synaptic plasticity in the adult hippocampus , 2020, Proceedings of the National Academy of Sciences.
[9] V. Stanton,et al. Tolerogenic nanoparticles suppress central nervous system inflammation , 2020, Proceedings of the National Academy of Sciences.
[10] R. Henry,et al. Gut microbiota–specific IgA+ B cells traffic to the CNS in active multiple sclerosis , 2020, Science Immunology.
[11] X. Montalban,et al. Role of B Cells in Multiple Sclerosis and Related Disorders , 2020, Annals of neurology.
[12] F. Quintana,et al. Astrocyte Crosstalk in CNS Inflammation , 2020, Neuron.
[13] M. Sofroniew. Astrocyte Reactivity: Subtypes, States, and Functions in CNS Innate Immunity. , 2020, Trends in immunology.
[14] Jasmin Herz,et al. Meningeal γδ T cells regulate anxiety-like behavior via IL-17a signaling in neurons , 2020, Biological Psychiatry.
[15] F. Quintana,et al. The Gut–CNS Axis in Multiple Sclerosis , 2020, Trends in Neurosciences.
[16] Jamie L. Marshall,et al. Disease-associated astrocytes in Alzheimer’s disease and aging , 2020, Nature Neuroscience.
[17] J. Kipnis,et al. Meningeal Immunity and Its Function in Maintenance of the Central Nervous System in Health and Disease. , 2020, Annual review of immunology.
[18] D. Geschwind,et al. Astrocyte layers in the mammalian cerebral cortex revealed by a single-cell in situ transcriptomic map , 2020, Nature Neuroscience.
[19] A. Molofsky,et al. Astrocytes and Microglia: In Sickness and in Health , 2020, Trends in Neurosciences.
[20] J. Ragoussis,et al. MAFG-driven astrocytes promote CNS inflammation , 2020, Nature.
[21] D. Rowitch,et al. Astrocyte Unfolded Protein Response Induces a Specific Reactivity State that Causes Non-Cell-Autonomous Neuronal Degeneration , 2020, Neuron.
[22] Mark M. Davis,et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease , 2020, Nature.
[23] C. Clish,et al. Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS , 2019, Cell.
[24] Maxim N. Artyomov,et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and - independent cellular responses in Alzheimer’s disease , 2019, Nature Medicine.
[25] B. Khakh,et al. Astrocyte molecular signatures in Huntington’s disease , 2019, Science Translational Medicine.
[26] Brigitta Stockinger,et al. Meningeal γδ T cell–derived IL-17 controls synaptic plasticity and short-term memory , 2019, Science Immunology.
[27] B. Khakh,et al. The Emerging Nature of Astrocyte Diversity. , 2019, Annual review of neuroscience.
[28] M. D’Elios,et al. A T Cell Suppressive Circuitry Mediated by CD39 and Regulated by ShcC/Rai Is Induced in Astrocytes by Encephalitogenic T Cells , 2019, Front. Immunol..
[29] B. Khakh,et al. Hyperactivity with Disrupted Attention by Activation of an Astrocyte Synaptogenic Cue , 2019, Cell.
[30] Manolis Kellis,et al. Single-cell transcriptomic analysis of Alzheimer’s disease , 2019, Nature.
[31] G. Getz,et al. Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39 , 2019, Nature Neuroscience.
[32] A. Bar-Or,et al. Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10 , 2019, Cell.
[33] F. Quintana,et al. The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease , 2019, Nature Reviews Immunology.
[34] F. Quintana,et al. Environmental Control of Astrocyte Pathogenic Activities in CNS Inflammation , 2019, Cell.
[35] A. Yoshimura,et al. Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery , 2019, Nature.
[36] A. Bar-Or,et al. Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10 , 2019, Cell.
[37] N. J. Allen,et al. Glia as architects of central nervous system formation and function , 2018, Science.
[38] Qingxiu Zhang,et al. MiR‐409‐3p and MiR‐1896 co‐operatively participate in IL‐17‐induced inflammatory cytokine production in astrocytes and pathogenesis of EAE mice via targeting SOCS3/STAT3 signaling , 2018, Glia.
[39] Peyman Golshani,et al. Reducing Astrocyte Calcium Signaling In Vivo Alters Striatal Microcircuits and Causes Repetitive Behavior , 2018, Neuron.
[40] Evan Z. Macosko,et al. Molecular Diversity and Specializations among the Cells of the Adult Mouse Brain , 2018, Cell.
[41] G. Courtine,et al. Required growth facilitators propel axon regeneration across complete spinal cord injury , 2018, Nature.
[42] M. London,et al. Astrocytic Activation Generates De Novo Neuronal Potentiation and Memory Enhancement , 2018, Cell.
[43] Marco Prinz,et al. Microglial control of astrocytes in response to microbial metabolites , 2018, Nature.
[44] D. McGavern,et al. Advances in Meningeal Immunity , 2018, Trends in Molecular Medicine.
[45] Y. Itoyama,et al. Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis , 2018, Journal of Neuroinflammation.
[46] Lars E. Borm,et al. Molecular Architecture of the Mouse Nervous System , 2018, Cell.
[47] Kevin W. Kelley,et al. Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development , 2018, Science.
[48] B. Becher,et al. High‐Dimensional Single‐Cell Mapping of Central Nervous System Immune Cells Reveals Distinct Myeloid Subsets in Health, Aging, and Disease , 2018, Immunity.
[49] Galina A. Erikson,et al. The Aging Astrocyte Transcriptome from Multiple Regions of the Mouse Brain , 2018, Cell reports.
[50] Y. Ao,et al. Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes , 2017, Proceedings of the National Academy of Sciences.
[51] Nicola J. Allen,et al. Cell Biology of Astrocyte-Synapse Interactions , 2017, Neuron.
[52] D. Hafler,et al. Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis , 2017, Nature Communications.
[53] T. Korn,et al. Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties , 2017, Journal of Neuroinflammation.
[54] Eduardo D. Martín,et al. Synapse-specific astrocyte gating of amygdala-related behavior , 2017, Nature Neuroscience.
[55] P. McMenamin,et al. Where are we? The anatomy of the murine cortical meninges revisited for intravital imaging, immunology, and clearance of waste from the brain , 2017, Progress in Neurobiology.
[56] Giovanni Coppola,et al. Neural Circuit-Specialized Astrocytes: Transcriptomic, Proteomic, Morphological, and Functional Evidence , 2017, Neuron.
[57] T. Dubovik,et al. High-dimensional, single-cell characterization of the brain's immune compartment , 2017, Nature Neuroscience.
[58] B. Khakh,et al. Unravelling and Exploiting Astrocyte Dysfunction in Huntington’s Disease , 2017, Trends in Neurosciences.
[59] I. Amit,et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease , 2017, Cell.
[60] F. Quintana,et al. Control of immune-mediated pathology via the aryl hydrocarbon receptor , 2017, The Journal of Biological Chemistry.
[61] R. Flavell,et al. Enhancement of IFNγ Production by Distinct Commensals Ameliorates Salmonella-Induced Disease. , 2017, Cell host & microbe.
[62] Yihui Bi,et al. IL-17 induces reactive astrocytes and up-regulation of vascular endothelial growth factor (VEGF) through JAK/STAT signaling , 2017, Scientific Reports.
[63] Benjamin R Arenkiel,et al. Identification of diverse astrocyte populations and their malignant analogs , 2017, Nature Neuroscience.
[64] Manoj Kumar,et al. INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.
[65] F. Shi,et al. Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity , 2016, Proceedings of the National Academy of Sciences.
[66] D. Rowitch,et al. Functional diversity of astrocytes in neural circuit regulation , 2016, Nature Reviews Neuroscience.
[67] C. Farina,et al. Astrocytes: Key Regulators of Neuroinflammation. , 2016, Trends in immunology.
[68] F. Quintana,et al. Regulation of the T Cell Response by CD39. , 2016, Trends in immunology.
[69] M. D’Elios,et al. The Adaptor Protein Rai/ShcC Promotes Astrocyte-Dependent Inflammation during Experimental Autoimmune Encephalomyelitis , 2016, The Journal of Immunology.
[70] Zhiping Weng,et al. Unexpected role of interferon-γ in regulating neuronal connectivity and social behavior , 2016, Nature.
[71] H. Weiner,et al. IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation , 2016, Brain : a journal of neurology.
[72] N. Pochet,et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and CNS inflammation via the aryl hydrocarbon receptor , 2016, Nature Medicine.
[73] Yan Ao,et al. Astrocyte scar formation aids central nervous system axon regeneration , 2016, Nature.
[74] Loren L Looger,et al. Dysfunctional Calcium and Glutamate Signaling in Striatal Astrocytes from Huntington's Disease Model Mice , 2016, The Journal of Neuroscience.
[75] Michael U. Martin,et al. Interleukin 33 is a guardian of barriers and a local alarmin , 2016, Nature Immunology.
[76] M. Matteoli,et al. Ectonucleotidase activity and immunosuppression in astrocyte-CD4 T cell bidirectional signaling , 2016, Oncotarget.
[77] R. Gold,et al. Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. , 2015, Immunity.
[78] T. Goldmann,et al. Fine-tuning of type I IFN-signaling in microglia — implications for homeostasis, CNS autoimmunity and interferonopathies , 2015, Current Opinion in Neurobiology.
[79] G. Perea,et al. Circuit-specific signaling in astrocyte-neuron networks in basal ganglia pathways , 2015, Science.
[80] F. Quintana,et al. Control of autoimmune CNS inflammation by astrocytes , 2015, Seminars in Immunopathology.
[81] I. Amit,et al. Host microbiota constantly control maturation and function of microglia in the CNS , 2015, Nature Neuroscience.
[82] C. Clish,et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α , 2015, Nature Medicine.
[83] M. Sofroniew. Astrocyte barriers to neurotoxic inflammation , 2015, Nature Reviews Neuroscience.
[84] S. Linnarsson,et al. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq , 2015, Science.
[85] N. J. Allen,et al. Astrocytes Control Synapse Formation, Function, and Elimination. , 2015, Cold Spring Harbor perspectives in biology.
[86] J. Koistinaho,et al. Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury , 2015, Brain, Behavior, and Immunity.
[87] Y. Ao,et al. Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis , 2014, Journal of Neuroimmunology.
[88] H. Weiner,et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation , 2014, Nature Medicine.
[89] カール エフ. ウェア,,et al. Regulation of γδT cell , 2014 .
[90] B. Trapp,et al. Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients , 2014, Acta neuropathologica communications.
[91] B. Trapp,et al. Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients , 2014, Acta Neuropathologica Communications.
[92] D. Pleasure,et al. Conditional Ablation of Astroglial CCL2 Suppresses CNS Accumulation of M1 Macrophages and Preserves Axons in Mice with MOG Peptide EAE , 2014, The Journal of Neuroscience.
[93] J. Godbout,et al. TGFβ produced by IL‐10 redirected astrocytes attenuates microglial activation , 2014, Glia.
[94] Kevin W. Kelley,et al. Astrocyte-encoded positional cues maintain sensorimotor circuit integrity , 2014, Nature.
[95] Y. Ao,et al. Heterogeneity of reactive astrocytes , 2014, Neuroscience Letters.
[96] Yan Ao,et al. Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice , 2014, Nature Neuroscience.
[97] J. Pachter,et al. Cell-selective knockout and 3D confocal image analysis reveals separate roles for astrocyte-and endothelial-derived CCL2 in neuroinflammation , 2014, Journal of Neuroinflammation.
[98] Stephen J. Smith,et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways , 2013, Nature.
[99] V. Kuchroo,et al. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39 , 2013, Nature Immunology.
[100] T. Goldmann,et al. Role of Microglia in CNS Autoimmunity , 2013, Clinical & developmental immunology.
[101] X. Y. Wang,et al. Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice , 2012, Clinical and experimental immunology.
[102] N. Arsenijević,et al. Deletion of IL-33R (ST2) Abrogates Resistance to EAE in BALB/C Mice by Enhancing Polarization of APC to Inflammatory Phenotype , 2012, PloS one.
[103] Elina A Kiss,et al. Aryl hydrocarbon receptor , 2012, Gut microbes.
[104] G. E. Vates,et al. A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β , 2012, Science Translational Medicine.
[105] A. Regev,et al. Induction and molecular signature of pathogenic TH17 cells , 2012, Nature Immunology.
[106] P. Staeheli,et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. , 2012, Immunity.
[107] D. Hinton,et al. IFN-γ Signaling to Astrocytes Protects from Autoimmune Mediated Neurological Disability , 2012, PloS one.
[108] A. Álvarez-Buylla,et al. Regional Astrocyte Allocation Regulates CNS Synaptogenesis and Repair , 2012, Science.
[109] M. Milovanovic,et al. IL‐33 attenuates EAE by suppressing IL‐17 and IFN‐γ production and inducing alternatively activated macrophages , 2012, European journal of immunology.
[110] Yaqing Wang,et al. IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice , 2012, Journal of Neuroimmunology.
[111] J. O’Shea,et al. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. , 2012, Annual review of immunology.
[112] F. Charron,et al. The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence , 2011, Science.
[113] K. Berer,et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination , 2011, Nature.
[114] F. Shi,et al. Organ-specific features of natural killer cells , 2011, Nature Reviews Immunology.
[115] Mark H. Ellisman,et al. Development of a Method for the Purification and Culture of Rodent Astrocytes , 2011, Neuron.
[116] B. Becher,et al. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation , 2011, Nature Immunology.
[117] F. Safavi,et al. The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF , 2011, Nature Immunology.
[118] R. Ransohoff,et al. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. , 2010, Immunity.
[119] D. Foureau,et al. Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis1 , 2009, The Journal of Immunology.
[120] P. Gourdy,et al. The pro‐Th2 cytokine IL‐33 directly interacts with invariant NKT and NK cells to induce IFN‐γ production , 2009, European journal of immunology.
[121] J. Ojemann,et al. Uniquely Hominid Features of Adult Human Astrocytes , 2009, The Journal of Neuroscience.
[122] T. Yamamura,et al. Immunopathology and Infectious Diseases NKT Cell-Dependent Amelioration of a Mouse Model of Multiple Sclerosis by Altering Gut Flora , 2010 .
[123] C. Giaume,et al. Gap Junction-Mediated Astrocytic Networks in the Mouse Barrel Cortex , 2008, The Journal of Neuroscience.
[124] D. Gomez-Nicola,et al. Interleukin 15 expression in the CNS: Blockade of its activity prevents glial activation after an inflammatory injury , 2008, Glia.
[125] D. Fitzgerald,et al. Suppressive Effect of IL-27 on Encephalitogenic Th17 Cells and the Effector Phase of Experimental Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.
[126] Kevin Eggan,et al. Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model , 2007, Nature Neuroscience.
[127] Steffen Jung,et al. Control of microglial neurotoxicity by the fractalkine receptor , 2006, Nature Neuroscience.
[128] Richard J. Miller,et al. Chemokines Regulate the Migration of Neural Progenitors to Sites of Neuroinflammation , 2006, The Journal of Neuroscience.
[129] J. Falsig,et al. The inflammatory transcriptome of reactive murine astrocytes and implications for their innate immune function , 2006, Journal of neurochemistry.
[130] G. Trinchieri,et al. Astrocytes as antigen‐presenting cells: expression of IL‐12/IL‐23 , 2005, Journal of neurochemistry.
[131] E. Coccia,et al. Astrocytes Produce Dendritic Cell-Attracting Chemokines In Vitro and in Multiple Sclerosis Lesions , 2005, Journal of neuropathology and experimental neurology.
[132] A. Rosenwald,et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma , 2005, The Journal of experimental medicine.
[133] Samia J. Khoury,et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[134] I. McInnes,et al. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. , 2004, Current opinion in pharmacology.
[135] Francesca Aloisi,et al. Chemokines and Glial Cells: A Complex Network in the Central Nervous System , 2004, Neurochemical Research.
[136] I. Bechmann,et al. Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152) , 2004, Journal of Molecular Medicine.
[137] W. Kuziel,et al. Chemokine Expression by Glial Cells Directs Leukocytes to Sites of Axonal Injury in the CNS , 2003, The Journal of Neuroscience.
[138] Richard J. Miller,et al. Chemokine receptors: signposts to brain development and disease , 2003, Nature Reviews Neuroscience.
[139] S. Youssef,et al. The Role of the MHC Class II Transactivator in Class II Expression and Antigen Presentation by Astrocytes and in Susceptibility to Central Nervous System Autoimmune Disease1 , 2002, The Journal of Immunology.
[140] R. Fields,et al. New insights into neuron-glia communication. , 2002, Science.
[141] E. Benveniste,et al. Immune function of astrocytes , 2001, Glia.
[142] G. Kollias,et al. CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity , 2001, Nature Neuroscience.
[143] B. Rollins,et al. Absence of Monocyte Chemoattractant Protein 1 in Mice Leads to Decreased Local Macrophage Recruitment and Antigen-Specific T Helper Cell Type 1 Immune Response in Experimental Autoimmune Encephalomyelitis , 2001, The Journal of experimental medicine.
[144] S. Zamvil,et al. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells , 1998, Journal of Neuroimmunology.
[145] Hervé Groux,et al. A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.
[146] L. Steinman,et al. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). , 1996, Journal of immunology.
[147] H. Hartung,et al. Antigen presentation by astrocytes primes rat T-lymphocytes for apoptotic cell death , 1994, Journal of Neuroimmunology.
[148] W. Fierz,et al. Astrocytes present myelin basic protein to encephalitogenic T-cell lines , 1984, Nature.
[149] J. Vanderhaeghen,et al. An acidic protein isolated from fibrous astrocytes. , 1971, Brain research.
[150] Andriezen Wl,et al. The Neuroglia Elements in the Human Brain , 1893 .
[151] B. Becher,et al. High-Dimensional Single-Cell Mapping of Central Nervous System Immune Cells Reveals Distinct Myeloid Subsets in Health, Aging, and Disease. , 2018, Immunity.
[152] A. Jafarzadeh,et al. Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis. , 2016, Oman medical journal.
[153] Y. Ao,et al. Astrocyte CCL 2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis , 2015 .
[154] C. Raine,et al. Role for CXCR2 and CXCL1 on glia in multiple sclerosis , 2006, Glia.
[155] R. Ransohoff,et al. The expression and function of chemokines involved in CNS inflammation. , 2006, Trends in pharmacological sciences.
[156] J. Newcombe,et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. , 2006, Brain : a journal of neurology.